Vaccine News and Research

Latest Vaccine News and Research

Detection of unreported infections based on SARS-CoV-2 antibody seroprevalence

Detection of unreported infections based on SARS-CoV-2 antibody seroprevalence

12 Dec 2022
Immunogenicity of SARS-CoV-2 antibody response in immune naïve children and adults

Immunogenicity of SARS-CoV-2 antibody response in immune naïve children and adults

12 Dec 2022
COVID vaccine hesitancy may be associated with increased risks of traffic accidents

COVID vaccine hesitancy may be associated with increased risks of traffic accidents

12 Dec 2022
XBB Omicron variant evades vaccine-induced immunity

XBB Omicron variant evades vaccine-induced immunity

12 Dec 2022
Researchers show link between a debilitating heart condition and COVID-19 infection, vaccination

Researchers show link between a debilitating heart condition and COVID-19 infection, vaccination

12 Dec 2022
The benefit-risk of the mRNA-1273 COVID-19 vaccine

The benefit-risk of the mRNA-1273 COVID-19 vaccine

12 Dec 2022
Knowledge and attitudes to mpox among GBMSM in Australia

Knowledge and attitudes to mpox among GBMSM in Australia

12 Dec 2022
Study shows emerging Omicron sublineages efficiently evade neutralization independent of immunization history

Study shows emerging Omicron sublineages efficiently evade neutralization independent of immunization history

12 Dec 2022
Reports of Mpox disease following recent vaccination

Reports of Mpox disease following recent vaccination

11 Dec 2022
Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice

Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice

11 Dec 2022
How convergent evolution is creating new COVID-19 waves

How convergent evolution is creating new COVID-19 waves

11 Dec 2022
Researchers seek to reduce Chikungunya virus-caused joint pain with new drug

Researchers seek to reduce Chikungunya virus-caused joint pain with new drug

9 Dec 2022
WashU’s nasal COVID-19 vaccine authorized for emergency use in India as a booster

WashU’s nasal COVID-19 vaccine authorized for emergency use in India as a booster

9 Dec 2022
HIV-positive people are protected by Covid vaccines

HIV-positive people are protected by Covid vaccines

9 Dec 2022
People show prejudice, discriminatory attitudes towards unvaccinated individuals during the pandemic

People show prejudice, discriminatory attitudes towards unvaccinated individuals during the pandemic

8 Dec 2022
Multi-stage HIV vaccine regimen shows promising results in Phase 1 clinical trial

Multi-stage HIV vaccine regimen shows promising results in Phase 1 clinical trial

8 Dec 2022
COVID-19 vaccines may reduce long-COVID symptoms

COVID-19 vaccines may reduce long-COVID symptoms

8 Dec 2022
The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein

The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein

From The Native Antigen Company 8 Dec 2022
Exploring a variant-adapted SARS-CoV-2 recombinant protein vaccine

Exploring a variant-adapted SARS-CoV-2 recombinant protein vaccine

8 Dec 2022
Exploring COVID-19 vaccination prioritization strategies for primary and booster doses

Exploring COVID-19 vaccination prioritization strategies for primary and booster doses

8 Dec 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback